Annan Yang, PhD
Scientist II
|
Annan Yang received her Ph.D in Cellular and Molecular Physiology from Johns Hopkins University in 2011, where she studied the impact of gene dosage of Ets2 in tumorigenesis in intestinal neoplasia, astrocytoma and skin carcinoma. She then joined Dr. Alec Kimmelman's lab ate the Dana Farber Cancer Institute to study the function of autophagy in Pancreatic cancer development in 2012. Currently Dr. Yang works as a staff scientist to work on in vivo testing of CDK inhibitors and development of new therapies for pancreatic cancer.
Contact: Annan_Yang@dfci.harvard.edu |